Elkem ASA

OB:ELK Lagerbericht

Marktkapitalisierung: NOK 17.2b

Elkem Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 1/6

ElkemDie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -25.1% zurückgegangen, während in der Branche Chemicals die Gewinne mit einer durchschnittlichen jährlichen Rate von 2.8% zurückgehen. Die Umsatzerlöse sind rückläufig mit einer durchschnittlichen Rate von 18.7% pro Jahr. Elkem Die Eigenkapitalrendite des Unternehmens beträgt 1.6%, und die Nettomargen liegen bei 1.8%.

Wichtige Informationen

-25.09%

Wachstumsrate der Gewinne

-25.49%

EPS-Wachstumsrate

Chemicals Wachstum der Industrie32.60%
Wachstumsrate der Einnahmen-18.74%
Eigenkapitalrendite1.60%
Netto-Marge1.82%
Nächste Ertragsaktualisierung10 Jul 2026

Jüngste Aktualisierungen vergangener Leistungen

Shareholders Shouldn’t Be Too Comfortable With Elkem's (OB:ELK) Strong Earnings

May 07
Shareholders Shouldn’t Be Too Comfortable With Elkem's (OB:ELK) Strong Earnings

Recent updates

ELK: New Three Division Structure And Workforce Cuts Will Support Upside

Analysts have made a small upward revision to Elkem's price target, moving it from NOK 33.14 to NOK 33.29. This reflects updated assumptions around revenue growth, profit margins and future P/E expectations.

ELK: New Three Division Structure And Cost Cuts Will Drive Upside

The analyst price target for Elkem has moved slightly higher to NOK33.14 from NOK32.83, with analysts citing adjustments in the assumed discount rate, revenue growth, profit margin, and future P/E to support the change. What's in the News Elkem is introducing a new corporate structure with three divisions: Elkem Silicon, Elkem Foundry Alloys and Elkem Carbon.

ELK: New Structure And Cost Cuts Will Support Future Upside

Analysts have kept their Elkem price target steady at NOK 32.83. They cite essentially unchanged assumptions for the discount rate, revenue growth, profit margin and future P/E as the basis for reaffirming their view.

ELK: Safety Actions And Stable Earnings Assumptions Will Support Upside Potential

Analysts have kept their fair value estimate for Elkem unchanged at NOK 32.83, with only small tweaks to assumptions on discount rate, revenue growth, profit margin and future P/E, which feed into an updated price target narrative. What's in the News An extraordinary general meeting on 9 March 2026 approved an amendment to Section 4 of Elkem ASA's articles of association, confirming share capital at NOK 1,505,514,210 divided into 301,102,842 shares with a nominal value of NOK 5 each (Key Developments).

ELK: Safety Actions And Earnings Assumptions Will Shape A Balanced Outlook

The analyst price target for Elkem has been adjusted from NOK 31.85 to NOK 32.83. Analysts cite updated assumptions across the discount rate, revenue growth, profit margin and forward P/E as the key drivers behind this change.

ELK: Safety Reforms After Saint Fons Incident Will Support Upbeat Outlook

Narrative Update on Elkem Analysts have kept their fair value estimate for Elkem steady at NOK 31.85. They explain the unchanged price target by slightly adjusting their assumptions for discount rate, revenue growth, profit margin and future P/E expectations, rather than changing their overall view of the company’s valuation.

ELK: Safety Incident And Minor Assumption Shifts Will Shape Balanced Outlook

Analysts have raised their fair value estimate for Elkem to €31.85 from €31.80, citing small adjustments to the discount rate, revenue growth, profit margin and forward P/E assumptions. What's in the News On 22 December 2025, an explosion occurred at a pilot workshop at the Elkem Silicones site in Saint Fons, Lyon, France, resulting in one employee losing his life and three others being injured (company report).

ELK: Medical Materials Push And Ferrosilicon Cuts Will Shape Balanced Outlook

Analysts now estimate Elkem's fair value at €31.80 per share, slightly higher than the previous estimate of €31.00, citing small adjustments to their discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Explosion at Elkem's Saint Fons silicones pilot workshop in Lyon on 22 December 2025 resulted in one fatality and three injuries, with management cooperating with local authorities and providing psychological support to employees (Key Developments).

ELK: Medical Materials Expansion And Ferrosilicon Curtailments Will Shape Measured Outlook

Analysts have raised their price target on Elkem to NOK 31.00 from NOK 29.80, reflecting updated assumptions of a slightly lower discount rate but higher future earnings multiples, despite somewhat softer expectations for revenue growth and profit margins. What's in the News Elkem ASA launched SILBIONE LSR Select EC 70, a next generation medical grade liquid silicone rubber engineered for wearable and diagnostic devices, combining high electrical conductivity, certified biocompatibility and enhanced process control (company announcement).

ELK: Medical Materials Expansion And Production Cuts Will Shape Balanced Outlook

Analysts have modestly raised their price target on Elkem to NOK 29.80, citing slightly lower perceived risk reflected in a reduced discount rate, while keeping growth, margin, and valuation assumptions broadly unchanged. What's in the News Elkem launched SILBIONE LSR Select EC 70, a next generation medical grade liquid silicone rubber designed for wearable and diagnostic devices, featuring high electrical conductivity, certified biocompatibility, and enhanced process control for precision healthcare applications (Key Developments).

ELK: New Medical-Grade Product Launch and Market Risks Will Shape Outlook

Analysts have maintained Elkem's fair value price target at NOK 29.80, citing stable underlying financial metrics and a slightly reduced discount rate as the basis for their decision. What's in the News Elkem ASA launched SILBIONE LSR Select EC 70, a next-generation medical-grade liquid silicone rubber designed for wearable and diagnostic devices.

ELK: Upcoming Medical Material Launch Will Support Increased Market Confidence

Narrative Update on Elkem: Analyst Price Target Revision Analysts have maintained their fair value estimate for Elkem at NOK 29.80. This reflects steady confidence in the company despite minor adjustments to key assumptions such as profit margin and growth projections.

Medical-Grade Silicone Launch and Production Cuts Will Balance Future Prospects

Analysts have raised their price target for Elkem from NOK 29.32 to NOK 29.80. This change reflects minor adjustments to their expectations for growth, discount rates, and profit margins.

Silicones Review And Carbon Capture R&D Will Improve Competitiveness

Elkem's analyst consensus price target has been raised from $27.92 to $29.32, reflecting analysts' expectations of slightly improved revenue growth and a lower discount rate that drives upward fair value adjustments. Valuation Changes The consensus analyst price target has increased from NOK 27.92 to NOK 29.32.

Silicones Review And Carbon Capture R&D Will Improve Competitiveness

Elkem's slight improvement in net profit margin has supported an upward revision of the consensus analyst price target from NOK26.40 to NOK27.92. What's in the News Elkem and NTE signed a long-term power purchase agreement for 300 GWh/year renewable power delivery (2028-2037) in Norway’s NO4 area.

Earnings Tell The Story For Elkem ASA (OB:ELK)

Sep 20
Earnings Tell The Story For Elkem ASA (OB:ELK)

Is Now The Time To Look At Buying Elkem ASA (OB:ELK)?

Jul 09
Is Now The Time To Look At Buying Elkem ASA (OB:ELK)?

Does Elkem (OB:ELK) Have A Healthy Balance Sheet?

Jun 17
Does Elkem (OB:ELK) Have A Healthy Balance Sheet?

Shareholders Shouldn’t Be Too Comfortable With Elkem's (OB:ELK) Strong Earnings

May 07
Shareholders Shouldn’t Be Too Comfortable With Elkem's (OB:ELK) Strong Earnings

Elkem (OB:ELK) Will Want To Turn Around Its Return Trends

Apr 29
Elkem (OB:ELK) Will Want To Turn Around Its Return Trends

Is It Too Late To Consider Buying Elkem ASA (OB:ELK)?

Mar 24
Is It Too Late To Consider Buying Elkem ASA (OB:ELK)?
User avatar

Carbon Capture Initiatives Will Strengthen ESG Positioning And Brand Value

Expansion in China and targeted operational improvements aim to boost EBITDA, enhancing revenue and earnings growth.

Investors Still Aren't Entirely Convinced By Elkem ASA's (OB:ELK) Revenues Despite 26% Price Jump

Feb 05
Investors Still Aren't Entirely Convinced By Elkem ASA's (OB:ELK) Revenues Despite 26% Price Jump

Here's Why Elkem (OB:ELK) Is Weighed Down By Its Debt Load

Jan 23
Here's Why Elkem (OB:ELK) Is Weighed Down By Its Debt Load

Market Still Lacking Some Conviction On Elkem ASA (OB:ELK)

Dec 19
Market Still Lacking Some Conviction On Elkem ASA (OB:ELK)

There May Be Reason For Hope In Elkem's (OB:ELK) Disappointing Earnings

Nov 02
There May Be Reason For Hope In Elkem's (OB:ELK) Disappointing Earnings

Elkem ASA Just Missed EPS By 51%: Here's What Analysts Think Will Happen Next

Oct 27
Elkem ASA Just Missed EPS By 51%: Here's What Analysts Think Will Happen Next

Little Excitement Around Elkem ASA's (OB:ELK) Revenues

Sep 04
Little Excitement Around Elkem ASA's (OB:ELK) Revenues

The Returns On Capital At Elkem (OB:ELK) Don't Inspire Confidence

Aug 07
The Returns On Capital At Elkem (OB:ELK) Don't Inspire Confidence

Elkem ASA Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Jul 17
Elkem ASA Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

These 4 Measures Indicate That Elkem (OB:ELK) Is Using Debt In A Risky Way

Jun 11
These 4 Measures Indicate That Elkem (OB:ELK) Is Using Debt In A Risky Way

Elkem ASA's (OB:ELK) Revenues Are Not Doing Enough For Some Investors

May 27
Elkem ASA's (OB:ELK) Revenues Are Not Doing Enough For Some Investors

Elkem ASA's (OB:ELK) Intrinsic Value Is Potentially 24% Below Its Share Price

May 11
Elkem ASA's (OB:ELK) Intrinsic Value Is Potentially 24% Below Its Share Price

Analysts Have Made A Financial Statement On Elkem ASA's (OB:ELK) First-Quarter Report

Apr 22
Analysts Have Made A Financial Statement On Elkem ASA's (OB:ELK) First-Quarter Report

What Does Elkem ASA's (OB:ELK) Share Price Indicate?

Apr 09
What Does Elkem ASA's (OB:ELK) Share Price Indicate?

Is Elkem (OB:ELK) A Risky Investment?

Dec 15
Is Elkem (OB:ELK) A Risky Investment?

Why Elkem ASA (OB:ELK) Could Be Worth Watching

Oct 23
Why Elkem ASA (OB:ELK) Could Be Worth Watching

Elkem (OB:ELK) Will Want To Turn Around Its Return Trends

Oct 04
Elkem (OB:ELK) Will Want To Turn Around Its Return Trends

Aufschlüsselung der Einnahmen und Ausgaben

Wie Elkem Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

OB:ELK Einnahmen, Ausgaben und Erträge (NOK Millions)
DatumEinnahmenGewinnAllgemeine und VerwaltungskostenF&E-Ausgaben
31 Dec 2516,5353012,8980
30 Sep 2516,8974852,9360
30 Jun 2516,9767002,8920
31 Mar 2517,4532,1232,8310
31 Dec 2417,8102,0262,7920
30 Sep 248,3083,2568780
30 Jun 2411,9002,3671,4380
31 Mar 2416,0581,0852,0800
31 Dec 2321,1341,9992,6830
30 Sep 2336,5171,4275,1680
30 Jun 2339,8204,9295,1590
31 Mar 2342,9887,8555,0620
31 Dec 2245,0179,5614,9790
30 Sep 2245,07310,6314,9140
30 Jun 2242,6718,9564,8460
31 Mar 2237,7336,6024,7280
31 Dec 2133,0834,6284,5780
30 Sep 2129,7792,7704,4380
30 Jun 2126,8561,2944,2190
31 Mar 2125,3876724,1100
31 Dec 2024,0252394,0600
30 Sep 2022,4981503,9190
30 Jun 2022,2604603,9140
31 Mar 2022,2046163,8190
31 Dec 1922,2458553,7270
30 Sep 1922,8401,2113,8280
30 Jun 1923,1381,9213,7300
31 Mar 1924,2823,1043,6670
31 Dec 1824,9683,3373,5840
30 Sep 1825,2163,6203,5270
30 Jun 1824,6803,0773,4570
31 Mar 1822,9952,0113,3910
31 Dec 1721,1331,2113,3030
31 Dec 1614,0457222,6960
31 Dec 1514,3618092,5610

Qualität der Erträge: ELK hat hohe Qualitätseinkünfte.

Wachsende Gewinnspanne: ELKDie aktuellen Gewinnspannen (1.8%) sind niedriger als im letzten Jahr (11.4%).

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: ELKDie Erträge des Unternehmens sind in den letzten 5 Jahren um 25.1% pro Jahr zurückgegangen.

Beschleunigtes Wachstum: ELKDas Unternehmen hat im vergangenen Jahr ein negatives Gewinnwachstum verzeichnet, so dass es nicht mit seinem 5-Jahres-Durchschnitt verglichen werden kann.

Erträge im Vergleich zur Industrie: ELK hatte im vergangenen Jahr ein negatives Gewinnwachstum (-85.1%), was einen Vergleich mit dem Branchendurchschnitt Chemicals (1.3%) erschwert.

Eigenkapitalrendite

Hohe Eigenkapitalrendite: ELKDie Eigenkapitalrendite des Unternehmens (1.6%) wird als niedrig angesehen.

Kapitalrendite

Rendite auf das eingesetzte Kapital

Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren

7D

1Y

7D

1Y

7D

1Y

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/02 01:59
Aktienkurs zum Tagesende2026/04/30 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Elkem ASA wird von 9 Analysten beobachtet. 6 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
null nullABG Sundal Collier
Sebastian SatzCitigroup Inc
Elliott Geoffrey JonesDanske Bank